Overview

Doloromicsis a seed-stage startup developing novel therapeutics to treat chronic pain. The team at Doloromicshas built a proprietary computational platform to identify drug targets within the human Dorsal Root Ganglion (DRG). Through a collaboration with NanoString, the company deeply sequenced and transcriptomically profiled nociceptors to uncover moderate-to-low expressed drug targets that would typically be overlooked by traditional sequencing methods. The results demonstrated by the team illuminate the ways in which the GeoMx® Digital Spatial Profiling platform can be used to facilitate an approach to precision medicine.

Utilizing Spatial Transcriptomics to Unlock Precision Pain Therapeutics
Utilizing Spatial Transcriptomics to Unlock Precision Pain Therapeutics
Utilizing Spatial Transcriptomics to Unlock Precision Pain Therapeutics

Utilizing Spatial Transcriptomics to Unlock Precision Pain Therapeutics

30 June 2022, 6:00:00 am
Jackson Brougher, Ph.D

Jackson Brougher, Ph.D

Chief Scientific Officer

Doloromics

Speakers

Utilizing Spatial

© 2021 Bioinnovations | Connecting Technologies to Life

Designed by Maveristic

Address

G1-G2, A-Wing, Hamirmal Tower, Station Rd, Bhayandar, Narayan Nagar, Bhayandar West, Mumbai, Maharashtra 401101, India

Quick Links